• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    More On 04I.SG

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    InVivo Therapeutics Holdings Corp. (04I.SG)

    -Stuttgart
    2.70 Up 1.55(134.08%) Mar 30
    Add to Portfolio
    Prev Close:0.72
    Open:2.41
    Bid:2.40
    Ask:2.95
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:2.41 - 2.41
    52wk Range:0.34 - 2.95
    Volume:100
    Avg Vol (3m):N/A
    Market Cap:69.10M
    P/E (ttm):N/A
    EPS (ttm):-0.84
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in EUR.

    Headlines

    • No Headlines available for 04I.SG at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Invivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focuses on developing and commercializing technologies for the treatment of spinal cord injury (SCI). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback